NIH funding

March 11, 2024

School of Medicine in top 10 in NIH funding: survey

Vanderbilt University School of Medicine, which received $527.7 million in direct and indirect NIH grant support in FY23, has been among the top 10 U.S. medical schools in NIH funding for six of the last 10 years.

By Bill Snyder
February 2, 2024

Study links small pancreas size to faster progression to stage 3 Type 1 diabetes

The study findings, published in the journal Diabetes Care, suggest that pancreas imaging can have a benefit in tracking disease development and recruitment for preventive and therapeutic trials.

By Jill Clendening
January 31, 2024

Fatty acids rewire energy supply chain in stomach cancer development

A study by Vanderbilt researchers has revealed how metabolic changes spurred by fatty acids contribute to the transformation of cells into abnormal versions of themselves that are the precursors to stomach cancer.

By Tom Wilemon
Blood clot simulation
November 10, 2023

Grant to advance prevention of hospital-acquired blood clots

A Vanderbilt team team will develop and test new clinical decision support tools to facilitate timely prevention of potentially lethal hospital-acquired blood clots, also known as venous thromboembolism.

By Paul Govern
Jordan Wright, MD, PhD, left, and Adel Eskaros, MBBS, PhD, are lead authors of the report on pancreatic exocrine-endocrine “crosstalk.” (photo by Susan Urmy)
November 1, 2023

Pancreas “crosstalk” may influence course of Type 1 and Type 2 diabetes

In the largest study of its kind, researchers at Vanderbilt have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms of diabetes, and with aging and obesity.

By Bill Snyder
October 27, 2023

Grant bolsters research to address rising maternal mortality rates

Study seeks to better understand the mechanism behind the association between preeclampsia and other hypertensive disorders of pregnancy and cardiovascular disease.

By Matt Batcheldor
October 17, 2023

VISE-affiliated researchers conduct phase 1 trial of novel magnetic endoscope for colonoscopies

A Vanderbilt research team is conducting the first phase 1 clinical trial of a magnetic, flexible endoscope that has the potential to provide a safer alternative to standard colonoscopy, particularly for individuals with inflammatory bowel disease.
By Jill Clendening
October 4, 2023

Vulnerability found in immunotherapy-resistant triple-negative breast cancer

Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
By Tom Wilemon
October 3, 2023

Research fellowship for genetic counselors established at Vanderbilt

Vanderbilt University School of Medicine has received a grant to establish a research fellowship for genetic counselors that will prepare them to contribute more fully to the advancement of personalized medicine.
By Bill Snyder
September 19, 2023

$51 million NIH grant brings ELVIS to VUMC

Vanderbilt University Medical Center scientists are launching a research platform called ELVIS that is devoted to molecular underpinnings of early-childhood determinants of health.
By Paul Govern
August 17, 2023

Grant aids drug discovery for autism, schizophrenia

Federal grant to help Vanderbilt researchers will pave the way for potential treatments for schizophrenia and autism spectrum disorder
By Paul Govern
July 20, 2023

Predicting gene expression may speed discovery: study

Researchers at Vanderbilt University Medical Center and the University of Cambridge have developed a method of or predicting gene expression in hard-to-access tissues like the brain from more accessible tissues, including whole blood.
By Bill Snyder
March 30, 2023

NIH grant launches C. diff vaccine research initiative

Vanderbilt has received an NIH grant to launch the Vanderbilt Antibody and Antigen Discovery for Clostridioides difficile Vaccines, or VANDy-CdV.
By Anthony Czelusniak
1 2 3 … 9